While the prohibition of cannabis is absurd, the ban on the plant’s non-psychoactive components is even more mind-boggling — particularly when it’s apparent that these compounds possess amazing therapeutic properties. Case in point: cannabidiol (CBD).
A just published scientific review by Sao Paulo University (Brazil) researcher Antonio Zuardi reports that there’s been an “explosive increase” of interest in CBD over the past five years. It’s apparent why.
Author: Paul Armentano, NORML Deputy Director
Last night’s Vice Presidential debate featured nary a word about drug policy, but did show — inadvertently — how American culture promotes booze while simultaneously stigmatizing cannabis.
Marijuana law reformers, myself included, have spilled volumes of ink commenting on the numerous reasons and vested interests responsible for the continued prohibition of cannabis. But while these lengthy writings may be worthwhile intellectual exercises, I fear that they overlook the obvious.
I’m pleased to see that the political left is finally beginning to emphasize the tragedy that is marijuana prohibition. Truth is: it is impossible in this day and age to talk about social justice, civil liberties, and economic equality without calling for an end to the “war on (some) drugs.”
The Hill is providing reformers with a valuable service by bringing our message prominently to Capitol Hill, and acting as a mediator in a high profile debate with the White House Office of National Drug Control Policy.
Voters in Massachusetts will decide this November on Question 2, which seeks to replace criminal penalties for the possession of up to one ounce of marijuana with a civil fine of no more than $100. Polls show that nearly three-out-of-four voters back the measure.
The Czar’s nose grew another six inches when he uncorked this whopper: “The fact is today, people don’t go to jail for the possession of marijuana. Finding somebody in jail or prison for possession of marijuana is like finding a unicorn. It doesn’t exist.”
Unfortunately, none of the four major Presidential or Vice Presidential candidates are prior recipients of NORML PAC funding — nor is it likely any of them will be in the future.
